Skip to content

DMAC

DiaMedica Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$7.87
+3.96%
Ask drillr

Leverage

Debt / equity
0.00x
Net debt / equity
-0.13x
Debt / assets
0.00x
Debt / EBITDA
-0.00x
Net debt / EBITDA
0.13x

Liquidity & coverage

Current ratio
6.72x
Quick ratio
6.72x
Cash ratio
6.60x
Interest coverage
—
EBITDA / interest
—
Working capital
$37.7M

Cash & dividend

FCF / debt
-170.81x
Cash flow / debt
-170.63x
Dividend per share
—
Dividend yield
—
Dividend growth 1y
—

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026